Processing

Please wait...

Settings

Settings

1. WO2020003009 - AN AUTOLOGOUS VACCINE AND A PREPARATION METHOD OF THE VACCINE AND MONITORING OF THE CANCER PATIENT DURING AND AFTER VACCINATION

Publication Number WO/2020/003009
Publication Date 02.01.2020
International Application No. PCT/IB2019/050752
International Filing Date 30.01.2019
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A61K 39/00 (2006.01)
G01N 33/00 (2006.01)
A61P 35/00 (2006.01)
CPC
A61K 2039/5154
A61K 35/13
A61K 35/15
A61K 35/17
A61K 39/0011
A61K 39/001102
Applicants
  • CELLPEUTICS SP. Z O.O. [PL/PL]; Duńska 9 54-424 Wroclaw, PL
Inventors
  • BOBEK, Vladimír; CZ
  • KOLOŠTOVÁ, Katarína; SK
Agents
  • SAUVAGE DE BRANTES, Petra; CZ
Priority Data
2018-30926.06.2018CZ
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) AN AUTOLOGOUS VACCINE AND A PREPARATION METHOD OF THE VACCINE AND MONITORING OF THE CANCER PATIENT DURING AND AFTER VACCINATION
(FR) VACCIN AUTOLOGUE ET PROCÉDÉ DE PRÉPARATION DU VACCIN ET SURVEILLANCE DU PATIENT CANCÉREUX PENDANT ET APRÈS LA VACCINATION
Abstract
(EN)
An autologous personalized immunotherapeutic anti-tumor vaccine using the immunization property of sporadic cells and their parts, methods of its production and the timing of its production and its administration to the patient based on monitoring of the patient, whereby monitoring relies on the real–time sporadic cell assessment. The vaccine can be used to invoke a personalized anti-tumor immune response in autologous vaccination, which causes an immunogenic reaction in the organism against the currently present tumor cells.
(FR)
Un vaccin anti-tumoral immunothérapeutique personnalisé autologue utilise la propriété d'immunisation de cellules sporadiques et de leurs parties, des procédés pour sa production et la synchronisation de sa production et son administration au patient sur la base de la surveillance du patient, la surveillance reposant sur l'évaluation de cellules sporadiques en temps réel. Le vaccin peut être utilisé pour invoquer une réponse immunitaire anti-tumorale personnalisée en vaccination autologue, ce qui provoque une réaction immunogène dans l'organisme contre les cellules tumorales actuellement présentes.
Latest bibliographic data on file with the International Bureau